{
    "cancer_info": {
        "cancer_name": "Cancer-Related Fatigue"
    },
    "diagnosis_recommendations": {
        "examinations": [
            "Brief Fatigue Inventory (BFI)",
            "Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)",
            "Multidimensional Fatigue Inventory (MFI)",
            "EORTC QLQ-FA12",
            "NCCN Distress Thermometer",
            "EORTC QLQ-C30 fatigue subscale",
            "Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF)",
            "PROMIS Fatigue CAT",
            "Comprehensive medical history review",
            "Physical exam (anemia, thyroid dysfunction)",
            "Laboratory tests: CBC, electrolytes, LFTs, renal function, CRP, vitamin D, thyroid panel",
            "Inflammatory biomarker tests: IL-1ra, sTNF-RII, neopterin, IL-6, TNF-Î±",
            "Pain assessment",
            "Emotional distress assessment (depression/anxiety)",
            "Sleep disturbance evaluation",
            "Nutritional status assessment",
            "Comorbidity evaluation (cardiac/pulmonary/endocrine dysfunction)"
        ]
    },
    "staging_treatment_plans": [
        {
            "staging_criteria": "Mild (1-3 on 0-10 scale)",
            "risk_group": "All",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Education and self-management",
                    "plan_details": "Patient/caregiver education on fatigue patterns, energy conservation, activity pacing, and medication review",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "General strategy"
                }
            ]
        },
        {
            "staging_criteria": "Moderate (4-6 on 0-10 scale)",
            "risk_group": "All",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Non-pharmacological interventions",
                    "plan_details": "Aerobic/resistance exercise (150 min/week moderate activity), yoga, tai chi, qigong",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Psychosocial therapies",
                    "plan_details": "Cognitive Behavioral Therapy (CBT), mindfulness-based stress reduction",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "With sleep disturbances",
                    "plan_name": "CBT for insomnia",
                    "plan_details": "Structured program to improve sleep hygiene and patterns",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "All",
                    "plan_name": "Acupuncture",
                    "plan_details": "Traditional acupuncture therapy",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        },
        {
            "staging_criteria": "Severe (7-10 on 0-10 scale)",
            "risk_group": "All",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Multimodal therapy",
                    "plan_details": "Combination of non-pharmacological interventions and pharmacological options",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "Advanced cancer/palliative care",
                    "plan_name": "Methylphenidate",
                    "plan_details": "5-20 mg/day (short-acting) or 18-72 mg/day (long-acting)",
                    "nccn_evidence_category": "Category 2B",
                    "nccn_recommendation_category": "Context-specific"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "End-of-life care",
                    "plan_name": "Dexamethasone",
                    "plan_details": "Short-term use (1-2 weeks) at 4 mg BID",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "Anemia present",
                    "plan_name": "Erythropoietin/transfusions",
                    "plan_details": "Administered when hemoglobin <10 g/dL",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        },
        {
            "staging_criteria": "Active Treatment",
            "risk_group": "Higher risk (chemotherapy/radiotherapy)",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Physical activity",
                    "plan_details": "Individualized aerobic/resistance program with safety precautions",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "After non-pharmacological failure",
                    "plan_name": "Methylphenidate",
                    "plan_details": "Cautious use after addressing modifiable causes",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        },
        {
            "staging_criteria": "Post-Treatment",
            "risk_group": "Survivors with persistent fatigue",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Exercise + CBT",
                    "plan_details": "Combined aerobic exercise and cognitive behavioral therapy",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Yoga/tai chi",
                    "plan_details": "Structured mind-body practices",
                    "nccn_evidence_category": "Category 1",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "With depression",
                    "plan_name": "SSRIs/bupropion",
                    "plan_details": "Pharmacological management of comorbid depression",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        },
        {
            "staging_criteria": "End-of-Life",
            "risk_group": "Advanced cancer",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Optimized activity",
                    "plan_details": "Tailored activity with safety precautions",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "All",
                    "plan_name": "Corticosteroids",
                    "plan_details": "Short-term dexamethasone or prednisone",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Preferred regimen"
                },
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "Symptom relief",
                    "plan_name": "Acupuncture/acupressure",
                    "plan_details": "Complementary therapy for rapid symptom management",
                    "nccn_evidence_category": "Category 2B",
                    "nccn_recommendation_category": "Context-specific"
                }
            ]
        },
        {
            "staging_criteria": "Anemia",
            "risk_group": "Hemoglobin <10 g/dL",
            "treatment_plans": [
                {
                    "treatment_line": "Second-line",
                    "patient_subgroup": "All",
                    "plan_name": "Erythropoietin/transfusions",
                    "plan_details": "Correction of anemia per NCCN Hematopoietic Growth Factors guidelines",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        },
        {
            "staging_criteria": "Nutritional deficits",
            "risk_group": "Malnutrition present",
            "treatment_plans": [
                {
                    "treatment_line": "Adjunctive",
                    "patient_subgroup": "All",
                    "plan_name": "Nutritional consultation",
                    "plan_details": "Dietary assessment and intervention",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "General strategy"
                },
                {
                    "treatment_line": "Adjunctive",
                    "patient_subgroup": "All",
                    "plan_name": "American Ginseng",
                    "plan_details": "2000 mg/day supplementation",
                    "nccn_evidence_category": "Category 2A",
                    "nccn_recommendation_category": "Other recommended regimen"
                }
            ]
        }
    ],
    "biomarker_clinical_significance": {
        "clinical_significance": "Elevated inflammatory cytokines (IL-6, TNF-Î±, IL-1ra, sTNF-RII, neopterin) correlate with fatigue severity and serve as targets for anti-inflammatory interventions. Hemoglobin levels <12 g/dL directly contribute to fatigue, with correction improving outcomes. Cortisol dysregulation (altered diurnal rhythm) is addressed by corticosteroids. Genetic polymorphisms (e.g., IL-6 rs1800795) are associated with persistent fatigue. Biomarkers guide management of modifiable factors but lack standalone diagnostic specificity."
    },
    "guideline_id": "ï¼2025.V1ï¼NCCNä¸´åºå®è·µæåï¼ççç¸å³ç²å³.txt"
}